Envue Medical moves NanoVibronix manufacturing to US in cost-cutting shift

Reuters2026/08/04 13:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Envue Medical completed a reorganization that shifted NanoVibronix manufacturing from Israel to the US to cut costs.
R&D operations were consolidated in Tel Aviv as part of a broader push to reduce operating expenses and improve cost structure.
The move brings all NanoVibronix production, including PainShield and UroShield, under US-based manufacturing to streamline the supply chain.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envue Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608040900PRIMZONEFULLFEED9802978) on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Envue Medical moves NanoVibronix manufacturing to US in cost-cutting shift

You may also like

Crypto prices